1. Quick Facts
| Property | Value |
|---|---|
| Category | Regenerative Multi-Peptide Blend |
| Risk Level | Moderate/High |
| Administration | Subcutaneous Injection |
| Typical Frequency | Nightly |
| Estimated Half-Life | Blend-Dependent / Multi-Phase Activity |
| Primary Research Interest | Injury Recovery / Tissue Repair / Inflammation Reduction |
This material is provided strictly for educational and informational purposes related to peptide research and regenerative compounds. Deadpool Stack (BPC-157 / TB-500 / KPV / GHK-Cu) is a multi-compound experimental peptide blend with limited formal human safety data. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.
2. Summary
Deadpool Stack (BPC-157 / TB-500 / KPV / GHK-Cu) is a regenerative multi-peptide blend combining four experimental compounds intended to support tissue recovery, inflammation modulation, collagen signaling, and soft tissue repair.
The blend attempts to combine multiple complementary regenerative pathways into a single injectable preparation. Interest in the stack primarily stems from the established popularity of its individual components rather than direct research evaluating the combination itself.
What People Commonly Claim
- Faster injury recovery than any individual component alone
- Powerful synergistic tissue repair effects
- Superior tendon, ligament, and soft tissue recovery
- Enhanced collagen production and skin health
- Reduced inflammation while simultaneously accelerating healing
- A “one-stop” regenerative blend that replaces multiple separate injections
What the Literature Actually Shows
- Published research exists for GHK-Cu, BPC-157, TB-500, and KPV individually.
- Each component has been investigated for different aspects of tissue repair, inflammation modulation, or regenerative signaling.
- No high-quality human studies directly evaluating Deadpool Stack as a combined formulation were identified.
- Claims regarding synergy between all four components remain largely theoretical and are based on extrapolation from the individual peptide literature.
- The efficacy and safety profile of the complete blend cannot currently be determined from published clinical evidence.
3. Reconstitution Guide
- Blend Composition: GHK-Cu 50 mg / BPC-157 10 mg / TB-500 10 mg / KPV 10 mg
- Blend Ratio: 5 : 1 : 1 : 1
- Total Vial Size: 80 mg
- Dilutant Type: BAC Water
- Amount of Dilutant Added: 2 mL
- Final Concentration: 40 mg/mL total blend concentration
At this concentration:
• 10 units = 0.10 mL
• 20 units = 0.20 mL
*Different vial sizes may limit reconstitution volume. If your product differs from the specifications listed here, please use the Peptide Calculator to calculate custom concentrations and dosing protocols.
4. Route of Administration
Deadpool Stack is most commonly discussed as a subcutaneous injectable regenerative peptide blend.
- Primary Route: SubQ Injection
- Preferred Timing: Evening / nighttime administration
- Administration Notes: Some users prefer administration near injured tissues, though systemic effects are also commonly discussed.
5. Common Research Protocols
- Product Strength: 40 mg/mL total blend concentration
- Typical Delivered Amount: 10–20 units daily
- Frequency: Each PM
- Cycle Length: 8–12 weeks on, PRN (as needed) for injury recovery
- Special Notes: Injection site sting is very common due to the high concentration of copper peptide. The solution should appear blue or turquoise when properly mixed. Swirl gently only and avoid vigorous mixing. Avoid prolonged room temperature exposure.
6. Mechanism of Action
Deadpool Stack combines several experimental peptides with overlapping but distinct regenerative signaling properties:
- GHK-Cu: Collagen signaling, copper peptide activity, tissue remodeling
- BPC-157: Angiogenesis and soft tissue recovery signaling
- TB-500: Cellular migration and tissue repair support
- KPV: Anti-inflammatory and immune modulation signaling
Together, the blend is intended to support:
- Tissue remodeling
- Inflammation reduction
- Recovery support
- Collagen signaling
- Soft tissue repair pathways
7. Potential Benefits
- Potential acceleration of soft tissue recovery
- Reduced inflammation signaling
- Enhanced collagen support
- Improved recovery from injury or training stress
- Potential skin and connective tissue benefits
- Broad regenerative pathway support
8. Potential Risks / Side Effects
Moderate/High
- Injection site irritation or stinging
- Localized redness or swelling
- Fatigue
- Nausea
- Potential abnormal angiogenesis concerns
- Limited long-term human safety data
- Possible immune or inflammatory signaling alterations
9. Half-Life
Because Deadpool Stack is a multi-peptide blend, pharmacokinetics vary significantly between individual components.
Some components demonstrate short plasma half-lives while downstream regenerative signaling effects may persist substantially longer.
10. Storage Information
- Store refrigerated before and after reconstitution
- Protect from direct light exposure
- Avoid repeated freeze-thaw cycles
- Avoid prolonged room temperature exposure
- Maintain sterile handling practices during preparation
11. Contraindications / Warnings
- Active cancer or cancer history
- Pregnancy or breastfeeding
- Use alongside experimental angiogenic compounds
- Known hypersensitivity to peptide compounds
- Severe inflammatory or autoimmune conditions
12. Further Study
No high-quality studies directly evaluating the complete Deadpool Stack (BPC-157 / TB-500 / KPV / GHK-Cu) formulation were identified during review.
Because the blend combines four separate experimental compounds, readers interested in evaluating the evidence should review the literature supporting each component individually.
Recommended Component Pages
- BPC-157 Tide Table
- TB-500 Tide Table
- KPV Tide Table
- GHK-Cu Tide Table
CKF Note: Claims regarding synergistic effects between the components of the Deadpool Stack are currently based on theoretical mechanisms, anecdotal reports, and extrapolation from individual peptide studies. No direct human clinical trials evaluating the complete blend were identified at the time of review.
13. Research References
- PubMed
- NIH Publications
- Experimental regenerative medicine literature
- Peer-reviewed tissue repair journals
14. Last Reviewed
June 2026
KLOW80: #213-110-550